Jason Barker - Net Worth and Insider Trading

Jason Barker Net Worth

The estimated net worth of Jason Barker is at least $5 dollars as of 2024-09-20. Jason Barker is the Sr.Dir.& Principal Actg.Ofcr. of ARYx Therapeutics Inc and owns about 10,000 shares of ARYx Therapeutics Inc (ARYX) stock worth over $5. Details can be seen in Jason Barker's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Jason Barker has not made any transactions after 2007-11-07 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Jason Barker

To

Jason Barker Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Jason Barker owns 2 companies in total, including Arcus Biosciences Inc (RCUS) , and ARYx Therapeutics Inc (ARYX) .

Click here to see the complete history of Jason Barker’s form 4 insider trades.

Insider Ownership Summary of Jason Barker

Ticker Comapny Transaction Date Type of Owner
RCUS Arcus Biosciences Inc 2019-10-01 See Remarks
ARYX ARYx Therapeutics Inc 2010-02-17 Sr.Dir.& Principal Acctg. Off.

Jason Barker Latest Holdings Summary

Jason Barker currently owns a total of 1 stock. Jason Barker owns 10,000 shares of ARYx Therapeutics Inc (ARYX) as of November 7, 2007, with a value of $5.

Latest Holdings of Jason Barker

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ARYX ARYx Therapeutics Inc 2007-11-07 10,000 0.00 5

Holding Weightings of Jason Barker


Jason Barker Form 4 Trading Tracker

According to the SEC Form 4 filings, Jason Barker has made a total of 0 transactions in ARYx Therapeutics Inc (ARYX) over the past 5 years. The most-recent trade in ARYx Therapeutics Inc is the sale of 0 shares on November 7, 2007, which brought Jason Barker around $0.

Insider Trading History of Jason Barker

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Jason Barker Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Jason Barker Ownership Network

Ownership Network List of Jason Barker

No Data

Ownership Network Relation of Jason Barker

Insider Network Chart

Jason Barker Owned Company Details

What does Arcus Biosciences Inc do?

Who are the key executives at Arcus Biosciences Inc?

Jason Barker is the See Remarks of Arcus Biosciences Inc. Other key executives at Arcus Biosciences Inc include Chief Accounting Officer Alexander Azoy , See Remarks Jennifer Jarrett , and director & 10 percent owner & President Juan C. Jaen .

Arcus Biosciences Inc (RCUS) Insider Trades Summary

Over the past 18 months, Jason Barker made no insider transaction in Arcus Biosciences Inc (RCUS). Other recent insider transactions involving Arcus Biosciences Inc (RCUS) include a net sale of 196,515 shares made by Jennifer Jarrett , a net purchase of 16,248,095 shares made by Gilead Sciences Inc , and a net sale of 34,007 shares made by Juan C. Jaen .

In summary, during the past 3 months, insiders sold 1,357 shares of Arcus Biosciences Inc (RCUS) in total and bought 0 shares, with a net sale of 1,357 shares. During the past 18 months, 238,214 shares of Arcus Biosciences Inc (RCUS) were sold and 16,248,095 shares were bought by its insiders, resulting in a net purchase of 16,009,881 shares.

Arcus Biosciences Inc (RCUS)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Arcus Biosciences Inc Insider Transactions

No Available Data

Jason Barker Mailing Address

Above is the net worth, insider trading, and ownership report for Jason Barker. You might contact Jason Barker via mailing address: Aryx Therapeutics, Inc., 6300 Dumbarton Circle, Fremont Ca 94555.

Discussions on Jason Barker

No discussions yet.